日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Deutenzalutamide, a novel androgen receptor inhibitor, after progression on docetaxel and abiraterone in metastatic castration-resistant prostate cancer: results from the randomized phase III HC-1119-04 trial

在转移性去势抵抗性前列腺癌患者接受多西他赛和阿比特龙治疗后出现疾病进展的情况下,新型雄激素受体抑制剂氘代沙鲁胺的疗效:来自随机 III 期 HC-1119-04 试验的结果

Wu, Junlong; Li, Xinghai; Gu, Chengyuan; Hua, Lixin; Liu, Ranlu; Li, Jun; Qiu, Mingxing; Guo, Jianming; Dong, Haiying; Ji, Zhigang; Xie, Liping; Zhu, Shaoxing; Zhang, Xuhui; Chen, Peng; Jiang, Shusuan; Sun, Zhongquan; Xu, Danfeng; Chen, Hui; Shi, Benkang; Wang, Yujie; Pu, Jinxian; Perabo, Frank; Chen, Yuanwei; Ye, Dingwei

Preliminary clinical practice of radical prostatectomy without preoperative biopsy

不经术前活检行根治性前列腺切除术的初步临床实践

Liu, Ranlu; Yin, Lu; Ma, Shenfei; Yang, Feiya; Lian, Zhenpeng; Wang, Mingshuai; Lei, Ye; Dong, Xiying; Liu, Chen; Chen, Dong; Han, Sujun; Xu, Yong; Xing, Nianzeng

Differentiation of high risk prostate cancer with a facile urinary exosome detection workflow.

利用简便的尿液外泌体检测流程区分高危前列腺癌

Qiu Shuai, Li Yue, Zhang Zheng, Li Chunchang, Wang Haoyu, Chen Ao, Yan Zhi, Liu Yang, Li Zifei, Huang Hua, Liu Yi, Seow Yiqi, Chen Ruibing, Guo Jinhong, Wen Simeng, Tian Jing, Zhang Hongtuan, Liu Ranlu, Han Gang, Wang Baolong, Wang Yong, Niu Yuanjie, Yin HaiFang

A manganese metabolism-related gene signature stratifies prognosis and immunotherapy efficacy in kidney cancer

锰代谢相关基因特征可对肾癌的预后和免疫治疗疗效进行分层

Liu, Yang; Ye, Hao; Zhang, Ruoxuan; Liu, Xiaolong; Liu, Ranlu

Development and validation of multivariable biopsy-free nomograms to predict clinically significant prostate cancer in patients with prostate-specific antigen levels ≥20 ng/mL

开发和验证无需活检的多变量列线图,以预测前列腺特异性抗原水平≥20 ng/mL患者中具有临床意义的前列腺癌。

Chen, Mingzhe; Guo, Shanqi; Wang, Junxin; Wang, Nan; Wen, Simeng; Zhang, Hongtuan; Wang, Yong; Liu, Ranlu; Xu, Yong; Jiang, Xingkang

Causal relationship between gut microbiota and male erectile dysfunction: a Mendelian randomization analysis

肠道菌群与男性勃起功能障碍的因果关系:孟德尔随机化分析

Chen, Shuaiqi; Liu, Xiaolong; Wu, Shangrong; Sun, Guangyu; Liu, Ranlu

A real-world pharmacovigilance study of FDA adverse event reporting system events for Lutetium-177-PSMA-617

一项针对镥-177-PSMA-617 的真实世界药物警戒研究,该研究纳入了 FDA 不良事件报告系统事件。

Wu, Shangrong; Hu, Wenjin; Chen, Mingzhe; Xiao, Xiong; Liu, Ranlu

[Corrigendum] Cripto‑1 promotes epithelial‑mesenchymal transition in prostate cancer via Wnt/β‑catenin signaling

[更正] Cripto-1 通过 Wnt/β-catenin 信号通路促进前列腺癌的上皮-间质转化

Liu, Yan; Qin, Zhenbang; Yang, Kuo; Liu, Ranlu; Xu, Yong

Trends in research on nanomedicine in urologic cancer: a bibliometric and visualized analysis

泌尿系统肿瘤纳米医学研究趋势:文献计量学和可视化分析

Lan, Xiaopeng; Feng, Mei; Chen, Lili; Zhang, Luchen; Han, Chao; Wang, Yizhen; Zheng, Jilu; Wang, Xiaoyan; Liu, Chunlei; Liu, Ranlu

Is switching intravesical chemotherapeutic agents beneficial in short-term recurrent high-risk non-muscle-invasive bladder tumors? A 5-year retrospective study

对于短期复发的高危非肌层浸润性膀胱肿瘤,更换膀胱内化疗药物是否有益?一项为期5年的回顾性研究

Chen, Shuaiqi; Sun, Guangyu; Chen, Xiaoxu; Salgado, Tiyara; Wu, Shangrong; Hu, Hailong; Liu, Ranlu; Qie, Yunkai